XTL BIOPHARMACEUTICALS LTD. Other Finance Income Cost
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Other Finance Income Cost of $495 for the 3-month period ending 2022-06-30, per its 6-K filed 2022-08-24.
Discontinued › Operating Expenses
ifrs-full:OtherFinanceIncomeCost · last filed 2022-08-24
- XTL BIOPHARMACEUTICALS LTD. other finance income cost for the quarter ending 2022-06-30 was $495.00.
| Period end | Other Finance Income Cost 3 month | Other Finance Income Cost 6 month | Other Finance Income Cost 12 month |
|---|---|---|---|
| 2022-06-30 | $495.00 6-K · filed 2022-08-24 | $1.03K 6-K · filed 2022-08-24 | |
| 2017-12-31 | $7.00K 20-F · filed 2018-03-15 | ||
| 2015-12-31 | -$6.00K 20-F · filed 2018-03-15 |